Stocks / Stock overview
Eton Pharmaceuticals, Inc. (ETON)
$59.78-4.61%Aft $59.78 (+0.00%)Market cap $1.71B
NasdaqGM · Price as of · Nasdaq Real Time Price
Stock Scorer
Scoring…
Analyst consensus
$71.00
- Analysts4
- Implied upside+18.8%
- Target range$68.00 to $76.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
in 75 days
- EPS expected$0.37 +825%
- A year ago$0.04
- Revenue expected$42.0M +87%
- Estimate range$0.32 to $0.42
Consensus of 2 analysts for the quarter ending September 30, 2026. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar
SEC filings
| Form | Filed | Description |
|---|---|---|
| 144 | August 28, 2026 | View on EDGAR |
| 4 | August 28, 2026 | FORM 4 |
| 4 | August 24, 2026 | FORM 4 |
| 144 | August 24, 2026 | View on EDGAR |
| 4 | August 20, 2026 | FORM 4 |
| 144/A | August 20, 2026 | View on EDGAR |
| 144 | August 19, 2026 | View on EDGAR |
| 10-Q | August 13, 2026 | FORM 10-Q |
Frequently asked questions
When does ETON report earnings?
Eton Pharmaceuticals, Inc. (ETON) is scheduled to report quarterly results on November 12, 2026. The 2-analyst consensus is $0.37 per share on revenue of $42.0M for the quarter ending September 30, 2026, against $0.04 and $22.5M a year earlier.
What do analysts expect for ETON?
4 analysts cover Eton Pharmaceuticals, Inc. (ETON). The consensus rating is Strong buy. The average price target is $71.00, in a range of $68.00 to $76.00.
Are insiders buying or selling ETON?
We have no qualifying Form 4 insider purchases or sales on record for Eton Pharmaceuticals, Inc. (ETON). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see ETON SEC filings?
Recent filings are listed on this page, newest first. The latest is a 144 filed August 28, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.